Search Results

Sling Therapeutics, Inc. today announced that Jeffrey Kent, M.D., FACG, FACP, has joined the company as Chief Medical Officer (CMO), effective immediately.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

NORTH CHICAGO, ILLINOIS, May 15, 2024 — Rosalind Franklin University’s Helix 51 biomedical incubator, the only one of its kind in Lake County, Illinois, celebrated its fifth year of...

Vivera Pharmaceuticals Inc., a leader in medical technology, biotech and biopharma, has bolstered its management team by adding Kent Barkouras as Chief Commercial Officer, the company announced.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

Agenus Inc. announced that the Compensation Committee of Agenus’ Board of Directors granted inducement awards to Nils Eckardt, Kent Barnes, and Brian Greenblatt, in connection with their appointments as Chief Medical Affairs Officer, Head of Marketing and Sales, and Vice President Commercial Operations and Business Analytics, respectively.

Maxwell Biosciences develops antiviral drugs, designed to be Zero-Day Therapeutics, which have been shown in preclinical studies to destroy a broad spectrum of viruses including rapidly evolving Coronavirus strains, announced the appointment of prominent New York University faculty member Kent Kirshenbaum, Ph.D., as the company’s Chief Scientific Officer.

MBX Biosciences, Inc. today announced that Kent Hawryluk, President and Chief Executive Officer, will present at the virtual Oppenheimer 34th Annual Healthcare Life Sciences Conference on Wednesday, February 14th , 2024, at 12:40 p.m. ET.